Teva Pharmaceutical Industries Ltd.’s plan to reformulate or repurpose existing drugs will generate $3 billion of sales by 2020, part of a strategy to counter a decline in revenue from its best-selling Copaxone multiple sclerosis treatment.
Former U.S. government contractor Edward Snowden should be prosecuted with no chance for clemency for divulging classified information, the nation’s two top lawmakers on intelligence issues said today.
The White House may have difficulty bolstering U.S. cyber defenses through an executive order unless there’s enough public support, according to former National Security Agency director Michael Hayden.
U.S. President Barack Obama’s call for more oversight and transparency in the National Security Agency’s surveillance programs shows that he wants to make Americans “more comfortable” with the agency’s operations, former NSA director Michael Hayden said.
Teva Pharmaceutical Industries Ltd. may be prepared to speed up the pace of acquisitions next year as Chief Executive Officer Jeremy Levin cuts costs and sets up a new management team, board member Chaim Hurvitz said.
Huawei Technologies Co., China’s largest maker of telecommunications equipment, denied that it poses a security threat after the former director of the U.S. Central Intelligence Agency said it spies for China.
The disclosure of National Security Agency secrets by 29-year-old computer systems technician Edward Snowden is drawing new scrutiny of security processes and U.S. intelligence agencies’ reliance on contractors such as Snowden’s employer, Booz Allen Hamilton Holding Corp.
Teva Pharmaceutical Industries Ltd. plans to double respiratory-treatment sales to $2 billion in the next five years, part of a strategy for countering a revenue decline from its best-selling Copaxone multiple sclerosis drug.